Featured

Featured Videos

Julianna LeMieux, PhD, GEN’s Deputy Editor-in-Chief took a minute away from the talks, posters, and expo hall to join Uduak Thomas, Senior Editor at GEN, who is also in Denver, to talk about the meeting, the sessions they attended, and the trends that they are noticing. Some of the highlights were an interview with Jacob Thaysen, Illumina’s new CEO, a single cell initiative, how proteomics is trying to change Alzheimer’s detection, and the launch of PacBio’s new instrument—the Vega—complete with a review of the OneRepublic concert.

Genomics in Snowy Denver: A Video Update from ASHG

John SterlingGEN’s Editor-in-Chief, has been attending BPI since its inception, 20 years ago! Here, he took a minute away from the talks and posters to join Julianna LeMieux, PhD, Deputy Editor-in-Chief—who was at BPI for her second time—to talk about the first day of the meeting, the sessions they attended, and the trends that they are noticing. John also reflects on 20 years in the industry.

Bioprocessing in Boston: GEN Reports Live from BPI 2024

GEN December 2024 cover

“In sight, in mind.” If the December issue of GEN has a theme, that’s it. Consider our cover story, which focuses on super-resolution microscopy technologies. Not only are they visualizing what was once too small to visualize, they are also generating data to clarify the relationships between molecules, revealing interactions and pathways of interest to drug developers. And just as seeing induces knowing, knowing can induce seeing, as when AI sifts through data to help drug developers “see” the vulnerabilities of high-value targets and the structural features that advantage some drug candidates over others. This “in mind, in sight” theme is developed in an article that summarizes a discussion from The State of AI in Drug Discovery, a GEN virtual summit. The theme is also evident in this issue’s A-List, “Ten Companies to Watch in AI Drug Discovery.” Other insightful content in this issue includes an interview with Illumina’s CEO, Jacob Thaysen.